Philippe Ohlmann

Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y1 receptor–null mice

Catherine Léon, Béatrice Hechler, Monique Freund et al. · Journal of Clinical Investigation · 1999 · 447 citations · Full text

Long-Term Antithrombotic Protection by in Vivo Depletion of Platelet Glycoprotein VI in Mice

Bernhard Nieswandt, Valerie Schulte, Wolfgang Bergmeier et al. · The Journal of Experimental Medicine · 2001 · 348 citations · Full text

Preparation of Washed Platelet Suspensions From Human and Rodent Blood

Jean‐Pierre Cazenave, Philippe Ohlmann, Dominique Cassel et al. · Humana Press eBooks · 2004 · 201 citations

Engineering, Biomedical Engineering, Prp Preparation +16

The P2Y₁ receptor, necessary but not sufficient to support full ADP‐induced platelet aggregation, is not the target of the drug clopidogrel

Béatrice Hechler, Anita Eckly, Philippe Ohlmann et al. · British Journal of Haematology · 1998 · 143 citations

Drug Clopidogrel, Pharmacotherapy, Platelet Aggregation +17

Purinoceptors on blood platelets: further pharmacological and clinical evidence to suggest the presence of two ADP receptors

Christian Gachet, Marco Cattaneo, Philippe Ohlmann et al. · British Journal of Haematology · 1995 · 129 citations